1
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Gary R Fabian, Barbara G McClung, February 14, 2012: US08114437 (14 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


2
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Gary R Fabian, Barbara G McClung, June 26, 2012: US08206745 (12 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


3
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles. Intarcia Therapeutics, Gary R Fabian, Barbara G McClung, July 3, 2012: US08211467 (11 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


4
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Gary R Fabian, Barbara G McClung, May 14, 2013: US08440226 (6 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


5
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Gary R Fabian, Barbara G McClung, June 11, 2013: US08460694 (6 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


6
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Cooley, August 4, 2015: US09095553 (6 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


7
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Cooley, December 27, 2016: US09526763 (3 worldwide citation)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


8
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Trask Britt, August 31, 2006: US20060193918-A1

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


9
Catherine M ROHLOFF, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Solvent/polymer solutions as suspension vehicles. Intarcia Therapeutics, Intarcia Therapeutics, November 25, 2010: US20100297209-A1

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...


10
Catherine M Rohloff, Guohua Chen, Andrew S Luk, Rupal A Ayer, Paul R Houston, Michael A Desjardin, Pauline Zamora, Stan Lam: Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles. Intarcia Therapeutics, May 5, 2011: US20110104111-A1

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be select ...